CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
MORBIUS focuses on developing a gene therapy for Osteogenesis Imperfecta by creating patient-derived bone organoids and using advanced gene editing techniques. The project aims to repair genetic defects in bone tissue, enhancing treatment options and quality of life for individuals with this rare condition.
Osteogenesis Imperfecta (OI), also known as brittle bone disease, is a prevalent rare skeletal condition.
With limited treatment options available and no known cure, individuals with OI endure numerous bone fractures throughout their lives.
To address the urgent need for an OI cure, MORBIUS aims to create a gene therapy: employ a cutting-edge AAV-mediated gene editing, to curatively repair the genetic defect in a model of patient bone tissue (mini brittle bone).
Within MORBIUS I will: 1) const…
FUNDACION PARA LA INVESTIGACION DE MALAGA EN BIOMEDICINA Y SALUD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Osteogenesis Imperfecta Federation Europe
Netherlands, Be Eindhoven
Type: Other
Activity type: Other
SME: No
United States, Amherst
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 topics.
Guests see up to 5 keywords.
